Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05501093 · ClinicalTrials.gov registry record
Diabetes Reversal and the Subgingival Microbiota
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 102
- Enrollment target
NCT05501093: Completed study, sponsored by University of Pennsylvania.
NCT05501093 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05501093 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
This study seeks to examine the impact of bariatric surgery on oral bacteria in diabetic compared to non-diabetic patients. The purpose of this research study is to examine how diabetes changes the bacteria in the mouth. This is an important question since bacterial changes may impact oral health. Participants will attend a screening and baseline visit prior to bariatric surgery and three post bariatric surgery appointments (3 weeks post, 6 months post and 1 year to 18 months post). Samples collected at each study visit include blood, plaque, and other oral samples. At the last study visit there is an optional dental cleaning.
Primary Outcome
as determined by 16s rRNA community profiling
Interventions
- OTHER sample collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2019-03-11 |
| Est. Completion | 2025-06-30 |
What the finished NCT05501093 record still lists
NCT05501093 is an observational study that tracks outcomes without assigning an intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which sample collection is the first listed.
NCT05501093 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05501093 about?
NCT05501093 is a clinical study titled "Diabetes Reversal and the Subgingival Microbiota". This study seeks to examine the impact of bariatric surgery on oral bacteria in diabetic compared to non-diabetic patients. The purpose of this research study is to examine how diabetes changes the bacteria in the mouth. This is an important question since bacterial changes may impact oral health. P...
What is the current status of trial NCT05501093?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2019-03-11. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT05501093?
The interventions under investigation include: sample collection (OTHER).
Who is sponsoring clinical trial NCT05501093?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI